NCI Launches Screening for High Genetic Risk Cancer Studies
The National Cancer Institute is conducting a screening survey to recruit participants for six open clinical genetics studies focused on cancer susceptibility.
Therapeutic Area
Therapeutic area intelligence for Genetic Risk Assessment with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.